This company creates novel, next-generation medicines using unique, long-acting therapeutic peptides.

This company was established in 1997 and their aim is to discover novel therapeutics with an initial focus on diabetes. They are focused on discovering and developing new drugs based on their novel technology platforms called Drug Affinity Complex (DACTM) and Performed Conjugate-Drug Affinity Complex (PC-DACTM).

Business Type: Nanotextile » | Biotechnology » | Electrotechnics » |


11755 Wilshire Blvd, Suite 2000,
90025 Los Angeles

Phone: 424-208-7025

Share with friends:  

Next companies in category